Login / Signup

Prosthetic Joint Infections due to Candida Species: A Multicenter International Study.

Aurélien DinhMartin McNallyEmma D'AnglejanChristel Mamona KiluJulie LourtetRosemary HoMatthew ScarboroughMaria DudarevaGerald JesuthasanCecile Ronde OustauStéphane KleinLaura Escolà-VergéDolores Rodriguez PardoPierre DelobelJaime Lora-TamayoMikel Mancheño-LosaMaria Luisa Sorlí RedóJosé María Barbero AllendeCédric ArvieuxDanguole VaznaisièneThomas BauerAnne-Laure RouxLatifa NoussairStéphane CorvecMarta Fernández-SampedroNicolò RossiAdrien LemaignenMauro José Costa SallesTaiana Cunha RibeiroJulien MazetMilène SassoJean-Philippe LavigneAlbert SottoEtienne CanouïÉric SennevillePauline ThillOlivier LortholaryFanny LanternierLaura MorataAlex SorianoGérard GiordanoCamille FourcadeBernhard J H FranckJochen G HofstätterClara DuranEric Bonnetnull null
Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Candida PJI prognosis seems poor, with high rate of failure, which does not appear to be linked to immunosuppression, use of azoles, or treatment duration.
Keyphrases
  • candida albicans
  • biofilm formation
  • clinical trial
  • pseudomonas aeruginosa
  • combination therapy
  • staphylococcus aureus
  • smoking cessation
  • genetic diversity